Madrigal Pharmaceuticals (0JXI.LSE) Q3 2024 Earnings

7AugConfirmed
Aug 21
Q4 2023
Q2 2024
Q3 2024
-7.54
-6.26
-4.99
-3.72

Details

Expected EPS
-7.536514
Actual EPS
-7.1
Surprise EPS
0.44
Surprise Percent
+5.79%

Description

Madrigal Pharmaceuticals (0JXI.LSE) has reported earnings of -7.1 per share for Q3 2024.

0 Comments

Share your thoughts